CODX — Co-Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- $35.95m
- -$22.60m
- $6.81m
- 37
- 36
- 82
- 50
Annual cashflow statement for Co-Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.2 | 42.5 | 36.7 | -14.2 | -35.3 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1.42 | 2.91 | 6.05 | 18 | 8.8 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.82 | -17.1 | -2.74 | 6.52 | 5.28 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -5.53 | 28.2 | 41.1 | 6.57 | -22.1 |
| Capital Expenditures | -0.113 | -0.774 | -0.669 | -1.43 | -1.37 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.322 | -5.05 | 4.77 | -56.7 | 16.8 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.435 | -5.82 | 4.1 | -58.2 | 15.4 |
| Financing Cash Flow Items | -0.593 | -1.46 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.9 | 19.7 | 0.45 | -14 | -1.36 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.057 | 42.1 | 45.6 | -65.6 | -8.06 |